Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia

El Rassi F, Khoury HJ

Pharmacogenomics and Personalized Medicine 2013, 6:57-62

Published Date: 5 August 2013